Grant to accelerate decarbonisation of cement for ADBRI

The federal government has awarded building materials group Adbri a $50 million grant as part of the Commonwealth’s Powering the Regions Fund which will speed decarbonisation of hard to abate cement production. The funds will increase capacity and production of lower carbon cementitious products at the company’s Birkenhead, Adelaide cement plant, South Australia’s largest. The…

Towards 3% R&D – innovation in biofuels by Geoff Bell of MicroBioGen

Biofuels are one of Australia’s biggest industrial and environmental opportunities. Today in our editorial series – Towards 3% R&D – Turbocharging Australia’s Innovation Effort – Geoff Bell looks at what is needed to make promise a reality. Australia, with its extensive demand for air travel and rich natural resources like biomass, solar and wind, is…

Cyclopharm achieves streamlined reimbursement for Technegas in the US

Cyclopharm’s Technegas radiopharmaceutical imaging system has achieved a streamlined reimbursement approval process in the United States, boosting its prospects in what is the world’s largest market. The Sydney company has received a Coding Determination for Technegas from the Center for Medicare Medicaid Services (CMS), which means users will have a unique identifier which streamlines their…

$22.5 million Early Career Industry Fellowships round supports research into atomic clocks, new batteries, soft electronics and more

The Australian Research Council (ARC) has announced $22.5 million in funding for 50 fellowships under the Industry Fellowships Program. Projects cover salary contributions for up to three years and project costs up to $150,000 under the program, which operates across industry, community organisation, not-for-profit, and other sectors and seeks “to facilitate the adoption, translation and…

State government awards support to IDT for nation’s first ADC factory

Pharmaceutical manufacturer IDT Australia has announced that it has been awarded a Victorian government grant to assist in the establishment of an Australian-first facility for oncology drugs. In an ASX statement on Monday, IDT said it has established relationships with Antibody-Drug-Conjugate (ADC) biotech companies, including a master services  agreement with Japanese pharmaceutical company Nagase &…

Signature Orthopaedics, RMIT, University of Melbourne to announce collaborative projects within months

Medical device and implants developer Signature Orthopaedics, RMIT University and the University of Melbourne have announced a new partnership, aiming to bring new personalised medical implant technologies to market. In a statement on Monday, the partnership was described as linking the company with research excellence in biomedical engineering, health, medicine, technology development and design. The…